Evidence map›Paper›PMID 39312212›Full record

ArticleAnalytical chemistry2024

Rapid Hyperspectral Photothermal Mid-Infrared Spectroscopic Imaging from Sparse Data for Gynecologic Cancer Tissue Subtyping.

Reza Reihanisaransari, Chalapathi Charan Gajjela, Xinyu Wu, Ragib Ishrak, Sara Corvigno, Yanping Zhong, Jinsong Liu, Anil K Sood, David Mayerich, Sebastian Berisha and 1 more

Abstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Reza ReihanisaransariDepartment of Electrical and Computer Engineering, University of Houston, Houston, Texas 77204, United States.
Chalapathi Charan GajjelaDepartment of Electrical and Computer Engineering, University of Houston, Houston, Texas 77204, United States.
Xinyu WuDepartment of Electrical and Computer Engineering, University of Houston, Houston, Texas 77204, United States.ORCID 0000-0002-7218-238X
Ragib IshrakDepartment of Electrical and Computer Engineering, University of Houston, Houston, Texas 77204, United States.
Sara CorvignoThe University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Yanping ZhongThe University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Jinsong LiuThe University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Anil K SoodThe University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
David MayerichDepartment of Electrical and Computer Engineering, University of Houston, Houston, Texas 77204, United States.ORCID 0000-0002-3949-6133
Sebastian BerishaMilwaukee School of Engineering, Milwaukee, Wisconsin 53202, United States.
Rohith ReddyDepartment of Electrical and Computer Engineering, University of Houston, Houston, Texas 77204, United States.ORCID 0000-0002-4403-5614

Funding

TRAINING PROGRAM IN COMPUTATIONAL BIOLOGY AND MEDICINET15LM007093 · NLM · RICE UNIVERSITY · PI Lydia E. Kavraki · 1992 to 2026
$20.8M
Structural and Molecular Phenotyping of Embryonic Development through Multi-Modal Optical ImagingR01HL146745 · NHLBI · UNIVERSITY OF HOUSTON · PI MAYERICH, DAVID · 2019 to 2023
$3.7M
Early detection of treatment response in myelofibrosis by polarization-sensitive mid-infrared spectroscopic imagingR01HL173597 · NHLBI · UNIVERSITY OF HOUSTON · PI Rohith Reddy · 2024 to 2026
$2.0M
Improving the Accuracy of Lupus Nephritis Diagnosis using Biomarkers Derived from Ultraviolet and Mid-infrared Spectroscopic ImagingR01DK135870 · NIDDK · UNIVERSITY OF HOUSTON · PI Rohith Reddy · 2024 to 2026
$1.8M
NHLBI NIH HHS R01 HL146745NHLBI NIH HHS R01 HL173597NIDDK NIH HHS R01 DK135870NLM NIH HHS T15 LM007093
6 · The paper itself

Abstract

Ovarian cancer detection has traditionally relied on a multistep process that includes biopsy, tissue staining, and morphological analysis by experienced pathologists. While widely practiced, this conventional approach suffers from several drawbacks: it is qualitative, time-intensive, and heavily dependent on the quality of staining. Mid-infrared (MIR) hyperspectral photothermal imaging is a label-free, biochemically quantitative technology that, when combined with machine learning algorithms, can eliminate the need for staining and provide quantitative results comparable to traditional histology. However, this technology is slow. This work presents a novel approach to MIR photothermal imaging that enhances its speed by an order of magnitude. This method resolves the longstanding trade-off between imaging resolution and data collection speed, enabling the reconstruction of high-quality, high-resolution images from undersampled data sets and achieving a 10X improvement in data acquisition time. We assessed the performance of our sparse imaging methodology using a variety of quantitative metrics, including mean squared error (MSE), structural similarity index (SSIM), and tissue subtype classification accuracies, employing both random forest and convolutional neural network (CNN) models, accompanied by Receiver Operating Characteristic (ROC) curves. Our statistically robust analysis, based on data from 100 ovarian cancer patient samples and over 65 million data points, demonstrates the method's capability to produce superior image quality and accurately distinguish between different gynecological tissue types with segmentation accuracy exceeding 95%. Our work demonstrates the feasibility of integrating rapid MIR hyperspectral photothermal imaging with machine learning in enhancing ovarian cancer tissue characterization, paving the way for quantitative, label-free, automated histopathology.

Indexed as

Spectrophotometry, InfraredFemaleGenital Neoplasms, FemaleHumansHyperspectral ImagingMachine LearningOvarian Neoplasms

Identifiers

PMID39312212
PMCPMC11521199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.